Diabetologia

Up Front

Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research

Jeremy Basset-Sagarminaga, Tineke van de Weijer, Patricia Iozzo, Patrick Schrauwen, Vera Schrauwen-Hinderling

The impact of taxing sugar-sweetened beverages on diabetes: a critical review

José L. Peñalvo

Type 2 diabetes and succinate: unmasking an age-old molecule

Sonia Fernández-Veledo, Anna Marsal-Beltran, Joan Vendrell

Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

Rabeeyah Ahmed, Russell J. de Souza, Vincent Li, Laura Banfield, Sonia S. Anand

Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study

Edward W. Gregg, Haiying Chen, Michael P. Bancks, Raoul Manalac, Nisa Maruthur, Medha Munshi, Rena Wing

Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

Matthias Blüher, Julio Rosenstock, Josef Hoefler, Raymond Manuel, Anita M. Hennige

Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study

Arunkumar Krishnan, Carolin V. Schneider, Yousaf Hadi, Diptasree Mukherjee, Bandar AlShehri, Saleh A. Alqahtani

Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study

Peter J. Raubenheimer, Joanna Skelton, Bukiwe Peya, Joel A. Dave, Naomi S. Levitt

MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial

Yoriko Heianza, Tao Zhou, Xuan Wang, Jeremy D. Furtado, Lawrence J. Appel, Frank M. Sacks, Lu Qi

Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018

Nolwenn Regnault, Elodie Lebreton, Luveon Tang, Sandrine Fosse-Edorh, Yaya Barry, Valérie Olié, Cécile Billionnet, Alain Weill, Anne Vambergue, Emmanuel Cosson

GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

Nikhil R. Gandasi, Rui Gao, Lakshmi Kothegala, Abigail Pearce, Cristiano Santos, Samuel Acreman, Davide Basco, Anna Benrick, Margarita V. Chibalina, Anne Clark, Claudia Guida, Matthew Harris, Paul R. V. Johnson, Jakob G. Knudsen, Jinfang Ma, Caroline Miranda, Makoto Shigeto, Andrei I. Tarasov, Ho Yan Yeung, Bernard Thorens, Ingrid W. Asterholm, Quan Zhang, Reshma Ramracheya, Graham Ladds, Patrik Rorsman

NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function

Sharon Baumel-Alterzon, Liora S. Katz, Luca Lambertini, Isabelle Tse, Fatema Heidery, Adolfo Garcia-Ocaña, Donald K. Scott

Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

Roshan Dhanapalaratnam, Tushar Issar, Alexandra T. K. Lee, Ann M. Poynten, Kerry-Lee Milner, Natalie C. G. Kwai, Arun V. Krishnan

Comments on the notion of false positivity in measurements of autoantibodies

Valdemar Grill, Elin Sørgjerd, Ingrid Hals, Sofia Carlsson

Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]

Nicholas J. Thomas, Angus G. Jones